首页> 美国卫生研究院文献>other >Development of Poly (β-amino esters)-Based Biodegradable Nanoparticles for Non-Viral Delivery of Minicircle DNA
【2h】

Development of Poly (β-amino esters)-Based Biodegradable Nanoparticles for Non-Viral Delivery of Minicircle DNA

机译:基于聚(β-氨基酯)的可生物降解的纳米粒子的非病毒传递小圆环DNA的发展。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Gene therapy provides a powerful tool for regulating cellular processes and tissue repair. Minicircle (MC) DNA are supercoiled DNA molecules free of bacterial plasmid backbone elements, and have been reported to enhance prolonged gene expression compared to conventional plasmids. Despite the great promise of MC DNA for gene therapy, methods for safe and efficient MC DNA delivery remain lacking. To overcome this bottleneck, here we report the development of a poly (β-amino ester) (PBAE)-based, biodegradable nanoparticulate platform for efficient delivery of MC DNA driven by an Ubc promoter in vitro and in vivo. By synthesizing and screening a small library of 18 PBAE polymers with different backbone and end-group chemistry, we identified lead cationic PBAE structures that can complex with minicircle DNA to form nanoparticles, and delivery efficiency can be further modulated by tuning PBAE chemistry. Using human embryonic kidney 293 cells and mouse embryonic fibroblasts as model cell types, we identified a few PBAE polymers that allow efficient MC delivery at levels that are comparable or even surpassing Lipofectamine 2000. The biodegradable nature of PBAE-based nanoparticles facilitates in vivo applications and clinical translation. When injected via intraperitoneal route in vivo, MC alone resulted in high transgene expression and a lead PBAE/MC nanoparticle formulation achieved a further 2-fold increase in protein expression compared to MC alone. Together, our results highlight the promise of PBAE-based nanoparticles as promising non-viral gene carriers for MC delivery, which may provide a valuable tool for broad applications of MC DNA-based gene therapy.
机译:基因疗法为调节细胞过程和组织修复提供了强大的工具。小环(MC)DNA是不含细菌质粒主链元件的超螺旋DNA分子,据报道与常规质粒相比可增强延长的基因表达。尽管MC DNA有望用于基因治疗,但仍缺乏安全有效地递送MC DNA的方法。为了克服这一瓶颈,我们在此报告了一种基于聚(β-氨基酯)(PBAE)的可生物降解的纳米粒子平台的开发,该平台可用于在体外和体内有效递送由Ubc启动子驱动的MC DNA。通过合成和筛选具有不同主链和端基化学性质的18个PBAE聚合物的小型文库,我们鉴定了可以与微环DNA络合形成纳米颗粒的阳离子铅PBAE结构,并且可以通过调节PBAE化学来进一步调节递送效率。使用人类胚胎肾293细胞和小鼠胚胎成纤维细胞作为模型细胞类型,我们确定了几种PBAE聚合物,它们能够以与Lipofectamine 2000相当甚至超过Lipofectamine 2000的水平有效地进行MC递送。基于PBAE的纳米颗粒的生物可降解性质促进了体内应用和临床翻译。当通过腹膜内途径体内注射时,单独的MC导致高的转基因表达,并且铅PBAE / MC纳米颗粒制剂与单独的MC相比,蛋白质表达进一步提高了2倍。在一起,我们的结果突出了基于PBAE的纳米颗粒作为有前景的非病毒基因载体用于MC传递的前景,这可能为基于MC DNA的基因治疗的广泛应用提供有价值的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号